Showing results (221-230 of 300) with videos related to
Sort By:
Pageof 30
ACS Applied Bio Materials|January 12, 2022
Two-Photon Fluorescence and Magnetic Resonance Specific Imaging of Aβ Amyloid Using Hybrid Nano-GdF3 Contrast MediaFrancis Mpambani, Andreas K O Åslund, Frederic Lerouge, et al.Scientific Reports|February 20, 2021
Causes of death and comorbidities in hospitalized patients with COVID-19Sefer Elezkurtaj, Selina Greuel, Jana Ihlow, et al.Journal of Neuroinflammation|July 2, 2022
Spermidine reduces neuroinflammation and soluble amyloid beta in an Alzheimer's disease mouse modelKiara Freitag, Nele Sterczyk, Sarah Wendlinger, et al.Neurology(R) Neuroimmunology & Neuroinflammation|May 25, 2016
Effective anti-Alzheimer Aβ therapy involves depletion of specific Aβ oligomer subtypesElysse M Knight, Soong Ho Kim, Jessica C Kottwitz, et al.Molecular Neurodegeneration|October 23, 2009
Dietary composition modulates brain mass and solubilizable Abeta levels in a mouse model of aggressive Alzheimer's amyloid pathologySteve Pedrini, Carlos Thomas, Hannah Brautigam, et al.Molecular Psychiatry|October 5, 2018
Integrative approach to sporadic Alzheimer's disease: deficiency of TYROBP in a tauopathy mouse model reduces C1q and normalizes clinical phenotype while increasing spread and state of phosphorylation of tauMickael Audrain, Jean-Vianney Haure-Mirande, Minghui Wang, et al.Journal of Alzheimer'S Disease : JAD|April 11, 2022
Making the Case for Accelerated Withdrawal of AducanumabPeter Whitehouse, Sam Gandy, Vikas Saini, et al.Acta Neuropathologica Communications|March 2, 2021
Laterality and region-specific tau phosphorylation correlate with PTSD-related behavioral traits in rats exposed to repetitive low-level blastGeorgina Perez Garcia, Rita De Gasperi, Miguel A Gama Sosa, et al.Annals of Neurology|July 20, 2010
Days to criterion as an indicator of toxicity associated with human Alzheimer amyloid-beta oligomersSam Gandy, Adam J Simon, John W Steele, et al.Neuroscience Letters|January 19, 2023
BCI-838, an orally active mGluR2/3 receptor antagonist pro-drug, rescues learning behavior deficits in the PS19 MAPTP301S mouse model of tauopathyGeorgina Perez-Garcia, Mesude Bicak, Jean-Vianney Haure-Mirande, et al.Pageof 30